Efficacy of Goreisan in transurethral resection of prostate
Not Applicable
- Conditions
- Patients who undergo transurethral resection of prostate because of benign prostatic hypertrophy
- Registration Number
- JPRN-UMIN000017135
- Lead Sponsor
- Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)emergency operation 2)simultaneously having different operation 3)serum potassium level <125mmol/l 4)having severe coronary diseases and cerebral vessel diseases 5)having severe liver dysfunctions 6)hyperkalemia 7)hemodialysis 8)permanent pacemaker 9)medication of CYP3A4 inhibitors 10)medication of vasopression related drugs 11)medication of inotropic agents 12)medication of Potassium-sparing diuretics 13)BMI>or=35 14)Coagulation disorder 15)Severe complication with a diagnosis of 6 months remaining 16)Participation in other intervention studies 17)being judged as not appropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change of serum potassium levels and occurrence of TUR syndrome
- Secondary Outcome Measures
Name Time Method 1) perioperative mortality 2) neurological and circuratory abnormality 3) serum creatinine levels 4) lactate levels